1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Detterbeck FC, Postmus PE and Tanoue LT:
The stage classification of lung cancer: Diagnosis and management
of lung cancer, 3rd ed: American college of chest physicians
evidence-based clinical practice guidelines. Chest. 143(5 Suppl):
e191S–e210S. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rea F, Zuin A, Callegaro D, Bortolotti L,
Guanella G and Sartori F: Surgical results for multiple primary
lung cancers. Eur J Cardiothorac Surg. 20:489–495. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Martini N and Melamed MR: Multiple primary
lung cancers. J Thorac Cardiovasc Surg. 70:606–612. 1975.PubMed/NCBI
|
5
|
Riquet M, Cazes A, Pfeuty K, Ngabou UD,
Foucault C, Dujon A and Banu E: Multiple lung cancers prognosis:
What about histology. Ann Thorac Surg. 86:921–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Arai J, Tsuchiya T, Oikawa M, Mochinaga K,
Hayashi T, Yoshiura K, Tsukamoto K, Yamasaki N, Matsumoto K,
Miyazaki T and Nagayasu T: Clinical and molecular analysis of
synchronous double lung cancers. Lung Cancer. 77:281–287. 2012.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Girard N, Ostrovnaya I, Lau C, Park B,
Ladanyi M, Finley D, Deshpande C, Rusch V, Orlow I, Travis WD, et
al: Genomic and mutational profiling to assess clonal relationships
between multiple non-small cell lung cancers. Clin Cancer Res.
15:5184–5190. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Girard N, Deshpande C, Azzoli CG, Rusch
VW, Travis WD, Ladanyi M and Pao W: Use of epidermal growth factor
receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation
testing to define clonal relationships among multiple lung
adenocarcinomas: Comparison with clinical guidelines. Chest.
137:46–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Shen C, Xu H, Liu L, Zhou Y, Chen D, Du H,
Han Z and Che G: ‘Unique trend’ and ‘contradictory trend’ in
discrimination of primary synchronous lung cancer and metastatic
lung cancer. BMC Cancer. 13:4672013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Pasic A, Vonk-Noordegraaf A, Risse EK,
Postmus PE and Sutedja TG: Multiple suspicious lesions detected by
autofluorescence bronchoscopy predict malignant development in the
bronchial mucosa in high risk patients. Lung Cancer. 41:295–301.
2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Braakhuis BJ, Tabor MP, Kummer JA, Leemans
CR and Brakenhoff RH: A genetic explanation of Slaughter's concept
of field cancerization: Evidence and clinical implications. Cancer
Res. 63:1727–1730. 2003.PubMed/NCBI
|
12
|
Chang YL, Wu CT, Lin SC, Hsiao CF, Jou YS
and Lee YC: Clonality and prognostic implications of p53 and
epidermal growth factor receptor somatic aberrations in multiple
primary lung cancers. Clin Cancer Res. 13:52–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kozower BD, Larner JM, Detterbeck FC and
Jones DR: Special treatment issues in non-small cell lung cancer:
Diagnosis and management of lung cancer, 3rd ed: American college
of chest physicians evidence-based clinical practice guidelines.
Chest. 143(5 Suppl): e369S–e399S. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shen C, Wang X, Tian L, Zhou Y, Chen D, Du
H, Wang W, Liu L and Che G: ‘Different trend’ in multiple primary
lung cancer and intrapulmonary metastasis. Eur J Med Res.
20:172015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ono K, Sugio K, Uramoto H, Baba T, Ichiki
Y, Takenoyama M, Hanagiri T, Oyama T and Yasumoto K: Discrimination
of multiple primary lung cancers from intrapulmonary metastasis
based on the expression of four cancer-related proteins. Cancer.
115:3489–3500. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen D, Mei L, Zhou Y, Shen C, Xu H, Niu Z
and Che G: A novel differential diagnostic model for multiple
primary lung cancer: Differentially-expressed gene analysis of
multiple primary lung cancer and intrapulmonary metastasis. Oncol
Lett. 9:1081–1088. 2015.PubMed/NCBI
|
17
|
Kalemkerian GP, Akerley W, Bogner P,
Borghaei H, Chow LQ, Downey RJ, Gandhi L, Ganti AK, Govindan R,
Grecula JC, et al: Small cell lung cancer. J Natl Compr Canc Netw.
11:78–98. 2013.PubMed/NCBI
|
18
|
Hann CL and Rudin CM: Management of
small-cell lung cancer: Incremental changes but hope for the
future. Oncology (Williston Park). 22:1486–1492. 2008.PubMed/NCBI
|
19
|
Jackman DM and Johnson BE: Small-cell lung
cancer. Lancet. 366:1385–1396. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Veronesi G, Bottoni E, Finocchiaro G and
Alloisio M: When is surgery indicated for small-cell lung cancer.
Lung Cancer. 90:582–589. 2015. View Article : Google Scholar : PubMed/NCBI
|